1 May 2025

Last updated: Tuesday 29 April 2025

Research Directory

What lies ahead for AstraZeneca

A new venture capital model

Antibodies and ADCs lead cancer pipeline

EU pharmacovigilance law comes into force

New study puts breast cancer into 10 subgroups

Commentary on the impact of pharmacovigilance legislation

Time to engage with stem-cell therapy

How tissue plasminogen activator was discovered

NICE exports its health technology expertise

Interview: 4-Antibody AG - How do you structure a biotech for divestment?